Ledger.Open graph →
SEC Form D · filed August 2, 2024

NILO Therapeutics, Inc

Offering
$101.0M
Sold
$9.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Tim Kutzkey · San Francisco, CAExec · Director · PromoterJeff Goater · Cambridge, MAExec · DirectorTim Kutzkey · San Francisco, CAExec · Director · PromoterJeff Goater · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗